VASOSTRICT

Drug Endo Pharmaceuticals Inc.
Total Payments
$885,992
Transactions
17
Doctors
3
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2022 $14,521 1 0
2021 $302,931 7 0
2020 $179,668 4 0
2019 $388,844 4 2
2018 $27.29 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $848,990 14 95.8%
Consulting Fee $36,975 2 4.2%
Food and Beverage $27.29 1 0.0%

Payments by Type

Research
$848,990
14 transactions
General
$37,002
3 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Phase 1, Open-Label, Two-Arm, Parallel-Group, Pharmacokinetic Study on Plasma Clearance of Vasopressin in Healthy Volunteers Endo Pharmaceuticals Inc. $848,990 0

Top Doctors Receiving Payments for VASOSTRICT

Doctor Specialty Location Total Records
Unknown Chicago, IL $848,990 14
, M.D Obstetrics & Gynecology Minneapolis, MN $19,425 1
, M.D., MPH Cardiovascular Disease Baltimore, MD $17,550 1
, MD, DPT Physical Medicine & Rehabilitation Martinsburg, WV $27.29 1

About VASOSTRICT

VASOSTRICT is a drug associated with $885,992 in payments to 3 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. The primary manufacturer is Endo Pharmaceuticals Inc..

Payment data is available from 2018 to 2022. In 2022, $14,521 was paid across 1 transactions to 0 doctors.

The most common payment nature for VASOSTRICT is "Unspecified" ($848,990, 95.8% of total).

VASOSTRICT is associated with 1 research study, including "A Phase 1, Open-Label, Two-Arm, Parallel-Group, Pharmacokinetic Study on Plasma Clearance of Vasopressin in Healthy Volunteers" ($848,990).